Advertisement

Current Medical Science

, Volume 39, Issue 1, pp 111–117 | Cite as

Apolipoprotein E Gene Polymorphisms Are Risk Factors for Spontaneous Intracerebral Hemorrhage: A Systematic Review and Meta-analysis

  • Hao Nie
  • Yang Hu
  • Na Liu
  • Ping Zhang
  • Gai-gai Li
  • Yan-yan Li
  • Chao Pan
  • Hai-han Yu
  • Qian Wu
  • Guo-feng WuEmail author
  • Zhou-ping TangEmail author
Article
  • 11 Downloads

Abstract

Intracerebral hemorrhage (ICH) is a serious clinical disease with high morbidity, whose pathogenesis might be related to apolipoprotein E (APOE) gene polymorphisms. To comprehensively evaluate the risk factors for ICH occurrence, we performed a meta-analysis. We searched online databases to identify eligible studies based on the relationship between APOE genetic polymorphisms and ICH occurrence risk. Specific and pooled odds ratios (ORs) were calculated and by assessing small study bias, we drew the relationship between APOE polymorphisms and ICH risk. We included 15 eligible studies in our study containing a total of 1642 ICH samples and 5545 normal controls. The comparison of ɛ4 and ɛ3 APOE genotypes revealed that specific and pooled ORs showed a significantly increased odds ratio in ICH patients with the ɛ4 genotype, indicating that ɛ4 gene is a risk factor for ICH occurrence, and the heterogeneity is acceptable. Similarly, it was found that the ɛ2 genotype also contributed to the incidence rate of ICH. However, after the subgroup analysis by ethnicity, this APOE genetic polymorphism acted as a harmful factor only in white populations, but did not show an effect in Asian populations. It was suggested that both ε2 and ε4 APOE alleles were risk factors for ICH in general. They were risk factors in white populations only, neither had a detectable effect in Asian populations after subgroup analysing by ethnicity.

Key words

intracerebral hemorrhage apolipoprotein E allele genetic polymorphism meta-analysis 

Preview

Unable to display preview. Download preview PDF.

Unable to display preview. Download preview PDF.

References

  1. 1.
    Brown RD, Whisnant JP, Sicks JD, et al. Stroke incidence, prevalence, and survival: secular trends in Rochester, Minnesota, through 1989. Stroke, 1996,27(3):373–380Google Scholar
  2. 2.
    Sturgeon JD, Folsom AR, Longstreth WJ, et al. Risk factors for intracerebral hemorrhage in a pooled prospective study. Stroke, 2007,38(10):2718–2725CrossRefGoogle Scholar
  3. 3.
    Mahley RW. Apolipoprotein E: cholesterol transport protein with expanding role in cell biology. Science, 1988,240(4852):622–630CrossRefGoogle Scholar
  4. 4.
    Hatters DM, Budamagunta MS, Voss JC, et al. Modulation of apolipoprotein E structure by domain interaction: differences in lipid–boud and lipid–free forms. J Biol Chem, 2005,280(40): 34 288–34 295CrossRefGoogle Scholar
  5. 5.
    Ophir G, Amariglio N, Jacob–Hirsch J, et al. Apolipoprotein E4 enhances brain inflammation by modulation of the NF–kappaB signaling cascade. Neurobiol Dis, 2005,20(3):709–718CrossRefGoogle Scholar
  6. 6.
    Atadzhanov M, Mwaba MH, Mukomena PN, et al. Association of the APOE, MTHFR and ACE Genes Polymorphisms and Stroke in Zambian Patients. Neurol Int, 2013,5(4):e20CrossRefGoogle Scholar
  7. 7.
    Boumendjel S, Khodja D, Hamri A, et al. Apolipoprotein E polymorphism and cerebral stroke. Ann Biol Clin (Paris), 2013,71(1):21–26Google Scholar
  8. 8.
    Chen YC, Lee–Chen GJ, Wu YR, et al. Analyses of interaction effect between apolipoprotein E polymorphism and alcohol use as well as cholesterol concentrations on spontaneous deep intracerebral hemorrhage in the Taiwan population. Clin Chim Acta, 2009,408(1–2):128–132CrossRefGoogle Scholar
  9. 9.
    Chowdhury AH, Yokoyama T, Kokubo Y, et al. Apolipoprotein E genetic polymorphism and stroke subtypes in a Bangladeshi hospital–based study. J Epidemiol, 2001,11(3):131–138CrossRefGoogle Scholar
  10. 10.
    Das S, Kaul S, Jyothy A, et al. Association of APOE (E2, E3 and E4) gene variants and lipid levels in ischemic stroke, its subtypes and hemorrhagic stroke in a South Indian population. Neurosci Lett, 2016,628:136–141CrossRefGoogle Scholar
  11. 11.
    Duzenli S, Pirim I, Gepdiremen A, et al. Apolipoprotein E polymorphism and stroke in a population from eastern Turkey. J Neurogenet, 2004,18(1):365–375CrossRefGoogle Scholar
  12. 12.
    Garcia C, Pinho EMT, Rocha L, et al. Cerebral hemorrhage and apoE. J Neurol, 1999,246(9): 830–834CrossRefGoogle Scholar
  13. 13.
    Kokubo Y, Chowdhury AH, Date C, et al. Agedependent association of apolipoprotein E genotypes with stroke subtypes in a Japanese rural population. Stroke, 2000,31(6):1299–1306CrossRefGoogle Scholar
  14. 14.
    Seifert T, Lechner A, Flooh E, et al. Lack of association of lobar intracerebral hemorrhage with apolipoprotein E genotype in an unselected population. Cerebrovasc Dis, 2006,21(4):266–270CrossRefGoogle Scholar
  15. 15.
    Tasdemir N, Tamam Y, Toprak R, et al. Association of apolipoprotein E genotype and cerebrovascular disease risk factors in a Turkish population. Int J Neurosci, 2008,118(8):1109–1129CrossRefGoogle Scholar
  16. 16.
    Woo D, Deka R, Falcone GJ, et al. Apolipoprotein E, statins, and risk of intracerebral hemorrhage. Stroke, 2013,44(11):3013–3017CrossRefGoogle Scholar
  17. 17.
    Zhang R, Wang X, Liu J, et al. Apolipoprotein E gene polymorphism and the risk of intracerebral hemorrhage in the Chinese population. Genet Test Mol Biomarkers, 2012,16(1):63–66CrossRefGoogle Scholar
  18. 18.
    Mccarron MO, Hoffmann KL, Delong DM, et al. Intracerebral hemorrhage outcome: apolipoprotein E genotype, hematoma, and edema volumes. Neurology, 1999,53(9):2176–2179CrossRefGoogle Scholar
  19. 19.
    Catto AJ, Mccormack LJ, Mansfield MW, et al. Apolipoprotein E polymorphism in cerebrovascular disease. Acta Neurol Scand, 2000,101(6):399–404CrossRefGoogle Scholar
  20. 20.
    Misra UK, Kalita J, Somarajan BI. Recurrent intracerebral hemorrhage in patients with hypertension is associated with APOE gene polymorphism: a preliminary study. J Stroke Cerebrovasc Dis, 2013,22(6):758–763CrossRefGoogle Scholar
  21. 21.
    Corder EH, Saunders AM, Strittmatter WJ, et al. Gene dose of apolipoprotein E type 4 allele and the risk of Alzheimer’s disease in late onset families. Science, 1993,261(5123):921–923CrossRefGoogle Scholar
  22. 22.
    Corder EH, Saunders AM, Risch NJ, et al. Protective effect of apolipoprotein E type 2 allele for late onset Alzheimer disease. Nat Genet, 1994,7(2):180–184CrossRefGoogle Scholar
  23. 23.
    Bartzokis G, Lu PH, Geschwind DH, et al. Apolipoprotein E affects both myelin breakdown and cognition: implications for age–related trajectories of decline into dementia. Biol Psychiatry, 2007,62(12):1380–1387CrossRefGoogle Scholar
  24. 24.
    Konialis C, Spengos K, Iliopoulos P, et al. The APOE E4 Allele Confers Increased Risk of Ischemic Stroke Among Greek Carriers. Adv Clin Exp Med, 2016,25(3):471–478CrossRefGoogle Scholar
  25. 25.
    Falcone GJ, Radmanesh F, Brouwers HB, et al. APOE epsilon variants increase risk of warfarinrelated intracerebral hemorrhage. Neurology, 2014,83(13):1139–1146CrossRefGoogle Scholar
  26. 26.
    Leclercq PD, Murray LS, Smith C, et al. Cerebral amyloid angiopathy in traumatic brain injury: association with apolipoprotein E genotype. J Neurol Neurosurg Psychiatry, 2005,76(2):229–233CrossRefGoogle Scholar
  27. 27.
    Greenberg SM, Vonsattel JP, Segal AZ, et al. Association of apolipoprotein E epsilon2 and vasculopathy in cerebral amyloid angiopathy. Neurology, 1998,50(4):961–965CrossRefGoogle Scholar
  28. 28.
    Tolar M, Keller JN, Chan S, et al. Truncated apolipoprotein E (ApoE) causes increased intracellular calcium and may mediate ApoE neurotoxicity. J Neurosci, 1999,19(16):7100–7110CrossRefGoogle Scholar
  29. 29.
    Lynch JR, Pineda JA, Morgan D, et al. Apolipoprotein E affects the central nervous system response to injury and the development of cerebral edema. Ann Neurol, 2002,51(1):113–117CrossRefGoogle Scholar
  30. 30.
    Davis SM, Broderick J, Hennerici M, et al. Hematoma growth is a determinant of mortality and poor outcome after intracerebral hemorrhage. Neurology, 2006,66(8):1175–1181CrossRefGoogle Scholar
  31. 31.
    Liaquat I, Dunn LT, Nicoll JA, et al. Effect of apolipoprotein E genotype on hematoma volume after trauma. J Neurosurg, 2002,96(1):90–96CrossRefGoogle Scholar
  32. 32.
    Biffi A, Anderson CD, Jagiella JM, et al. APOE genotype and extent of bleeding and outcome in lobar intracerebral haemorrhage: a genetic association study. Lancet Neurol, 2011,10(8):702–709CrossRefGoogle Scholar
  33. 33.
    Alberts MJ, Graffagnino C, Mcclenny C, et al. ApoE genotype and survival from intracerebral haemorrhage. Lancet, 1995,346(8974):575CrossRefGoogle Scholar
  34. 34.
    Raffeld MR, Biffi A, Battey TW, et al. APOE epsilon4 and lipid levels affect risk of recurrent nonlobar intracerebral hemorrhage. Neurology, 2015,85(4):349–356CrossRefGoogle Scholar

Copyright information

© Huazhong University of Science and Technology 2019

Authors and Affiliations

  • Hao Nie
    • 1
  • Yang Hu
    • 1
  • Na Liu
    • 1
  • Ping Zhang
    • 1
  • Gai-gai Li
    • 1
  • Yan-yan Li
    • 1
  • Chao Pan
    • 1
  • Hai-han Yu
    • 1
  • Qian Wu
    • 1
  • Guo-feng Wu
    • 2
    Email author
  • Zhou-ping Tang
    • 1
    Email author
  1. 1.Department of Neurology, Tongji Hospital, Tongji Medical CollegeHuazhong University of Science and TechnologyWuhanChina
  2. 2.Affiliated Hospital of Guizhou Medical UniversityGuiyangChina

Personalised recommendations